To our knowledge, this is the first report to demonstrate the clinical and cytogenetic manifestations of <i>BCR::PDGFRA</i> positive myeloid neoplasm coexisting <i>PDGFRA</i> mutations. Here, BCR is linked to myeloid neoplasm.